These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 30477056)

  • 41. Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis.
    Lee DM; Phillips R; Hagan EM; Chibnik LB; Costenbader KH; Schur PH
    Ann Rheum Dis; 2009 Feb; 68(2):201-8. PubMed ID: 18390910
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
    Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
    J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
    Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E
    Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
    Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis.
    Barouta G; Katsiari CG; Alexiou I; Liaskos C; Varna A; Bogdanos DP; Germenis AE; Sakkas LI
    Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis.
    Baecklund E; Backlin C; Rönnelid J; Toes R; Huizinga T; Åhlin E; Askling J; Hochberg FH; Klareskog L; Kay J; Smedby KE
    Scand J Rheumatol; 2018 Jul; 47(4):270-275. PubMed ID: 29336646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis.
    Alexiou I; Germenis A; Ziogas A; Theodoridou K; Sakkas LI
    BMC Musculoskelet Disord; 2007 Apr; 8():37. PubMed ID: 17448247
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-carbamylated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: lack of correlation with anti-cyclic citrullinated protein antibodies and rheumatoid factor.
    Alessandri C; Bartosiewicz I; Pendolino M; Mancini R; Colasanti T; Pecani A; Morello F; Mastrangelo A; Sabatinelli D; Riccieri V; Di Franco M; Ceccarelli F; Perricone C; Conti F; Valesini G
    Clin Exp Rheumatol; 2015; 33(6):824-30. PubMed ID: 26411477
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
    Liu X; Jia R; Zhao J; Li Z
    J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ethnic differences in the prognostic utility of rheumatoid factor isotypes and anticyclic citrullinated peptides in rheumatoid arthritis patients: a cross-sectional study.
    Gomez EL; Gun SC; Somanath SD; Chinna K; Radhakrishnan AK
    Mod Rheumatol; 2013 Jul; 23(4):716-21. PubMed ID: 22854883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-cyclic citrullinated peptide antibodies in patients with sarcoidosis.
    Kobak S; Ylmaz H; Sever F; Duran A; Sen N
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Oct; 31(3):206-10. PubMed ID: 25363220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Detection of antibodies to cyclic citrullinated peptides and its clinical significance in patients with chronic hepatitis B virus infection].
    Zhou RF; Liu XF; Chen Y; Wu F; Zeng AP; Cheng YJ
    Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(22):1536-9. PubMed ID: 22944056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis.
    Koivula MK; Heliövaara M; Ramberg J; Knekt P; Rissanen H; Palosuo T; Risteli J
    Ann Rheum Dis; 2007 Nov; 66(11):1450-5. PubMed ID: 17472989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-carbamylated Protein Antibody Levels Correlate with Anti-Sa (Citrullinated Vimentin) Antibody Levels in Rheumatoid Arthritis.
    Challener GJ; Jones JD; Pelzek AJ; Hamilton BJ; Boire G; de Brum-Fernandes AJ; Masetto A; Carrier N; Ménard HA; Silverman GJ; Rigby WFC
    J Rheumatol; 2016 Feb; 43(2):273-281. PubMed ID: 26669911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic value of anti-modified citrullinated vimentin in rheumatoid arthritis.
    Maraina CH; Nurdayana AK; Rusni D; Azwany Y
    Int J Rheum Dis; 2010 Oct; 13(4):335-9. PubMed ID: 21199468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Performance characteristic of anti-cyclic citrullinated peptide (CCP) assay on Korean rheumatoid arthritis (RA) patients and healthy controls.
    Pyun JC; Lee EH; Han H; Kim HY; Kim HO; Kang MJ
    J Pharm Biomed Anal; 2014 Apr; 92():69-73. PubMed ID: 24503194
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis.
    Berglin E; Padyukov L; Sundin U; Hallmans G; Stenlund H; Van Venrooij WJ; Klareskog L; Dahlqvist SR
    Arthritis Res Ther; 2004; 6(4):R303-8. PubMed ID: 15225365
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PREVALENCE OF ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS CLASSIFIED AS RHEUMATOID AND UNDIFFERENTIATED ARTHRITIS AT KENYATTA NATIONAL HOSPITAL.
    Ayunga AO; Oyoo GO; Amayo EO; Angela AA
    East Afr Med J; 2012 Jun; 89(6):206-11. PubMed ID: 26856043
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peptidyl-arginine deiminase: an additional marker of rheumatoid arthritis.
    Basu PS; Majhi R; Ghosal S; Batabyal SK
    Clin Lab; 2011; 57(11-12):1021-5. PubMed ID: 22239037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.